Trial Profile
Flunisolide HFA in Children With Small Airway Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Flunisolide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 21 Sep 2017 Status changed from recruiting to completed.
- 03 May 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 03 May 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.